DCM Shriram, Raymond, and Natco Pharma show undervaluation with varying quality and momentum, while Nuvama and SBI Cards enjoy bullish sentiment. Trent’s valuation remains high despite strong fundamentals.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets